Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 10/2010

01-10-2010 | Review

Morbid Obesity and Sleeve Gastrectomy: How Does It Work?

Authors: Joanna Papailiou, Konstantinos Albanopoulos, Konstantinos G. Toutouzas, Christos Tsigris, Nikolaos Nikiteas, George Zografos

Published in: Obesity Surgery | Issue 10/2010

Login to get access

Abstract

Laparoscopic sleeve gastrectomy is known to be a safe and effective procedure for treating morbid obesity and is performed with increasing frequency both in Europe and the USA. Despite its broad use, many questions about the remaining gastric tube diameter, its long-term efficacy, its effects on gastric emptying, and the hormones involved still remain to be answered. In order to use such a relatively new surgical procedure wisely, it is essential for every surgeon and physician to understand how sleeve gastrectomy acts in obesity and what its potential benefits on the patients’ metabolism are. This review focuses on the most important pathophysiologic questions referred to sleeve gastrectomy on the literature so far, in an attempt to evaluate the different issues still pending on the subject.
Literature
1.
Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. Position statement: sleeve gastrectomy as a bariatric procedure. Surg Obes Rel Dis. 2007;3:573–6.CrossRef
2.
Deitel M, Crosby R, Gagner M. The first international consensus summit for sleeve gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg. 2008;18:487–96.CrossRefPubMed
3.
Mognol P, Chosidow D, Marmuse J. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg. 2005;15:1030–3.CrossRefPubMed
4.
Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007;21:1810–6.CrossRefPubMed
5.
Himpens J, Dapri G, Cadiere G. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–6.CrossRefPubMed
6.
Han MS, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469–75.CrossRef
7.
Moy J, Pomp A, Dakin A, et al. Laparoscopic sleeve gastrectomy for morbid obesity. Am J Surg. 2008;196:e56–9.CrossRefPubMed
8.
Akkary E, Duffy A, Bell R. Deciphering the sleeve: technique, indications, efficacy, and safety of sleeve gastrectomy. Obes Surg. 2008;18:1323–9.CrossRefPubMed
9.
Frezza E. Laparoscopic vertical sleeve gastrectomy for morbid obesity: the future procedure of choice? Surg Today. 2007;37:275–81.CrossRefPubMed
10.
Langer F, Bohdjalian A, Felberbauer F, et al. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg. 2006;16:166–71.CrossRefPubMed
11.
Roa PE, Kaidar-Person O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcomes. Obes Surg. 2006;16:1323–6.CrossRefPubMed
12.
Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI ≥ 50). Obes Surg. 2005;15:612–7.CrossRefPubMed
13.
Perikh M, Gagner M, Heacock L. Laparoscopic sleeve gastrectomy: does bougie size affect mean %EWL? Short-term outcomes. Surg Obes Rel Dis. 2008;4:528–33.CrossRef
14.
15.
Frezza EE, Chiriva-Internati M, Wachtel MS. Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin. Surg Today. 2008;38:481–3.CrossRefPubMed
16.
Weiner RA, Weiner S, Pomhoff I, et al. Laparoscopic sleeve gastrectomy—influence of sleeve size and resected gastric volume. Obes Surg. 2007;17:1297–305.CrossRefPubMed
17.
Baltasar A, Serra C, Perez N, et al. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg. 2005;15:1124–8.CrossRefPubMed
18.
Yehoshua RT, Eidelman LA, Stein M, et al. Laparoscopic sleeve gastrectomy—volume and pressure assessment. Obes Surg. 2008;18:1083–8.CrossRefPubMed
19.
Schwartz GJ, McHugh PR, Moran TH. Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents. Am J Physiol. 1993;265:R872–6.PubMed
20.
Piessevaux H, Coulie B, Caenepeel P, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115:1346–52.CrossRefPubMed
21.
Gagner M, Deitel M, Kalberer TL, et al. Symposium review: the second international consensus summit for sleeve gastrectomy, March 19–21, 2009. Surg Obes Rel Dis. 2009;5:476–85.CrossRef
22.
Gagner M, Rogula T. Laparoscopic reoperative sleeve gastrectomy for poor weight loss after biliopancreatic diversion with duodenal switch. Obes Surg. 2003;13:649–54.CrossRefPubMed
23.
Keidar A, Appelbaum L, Schweiger C, et al. Dilated upper sleeve can be associated with severe postoperative gastroesophageal dysmotility and reflux. Obes Surg. 2010;20:140–7.CrossRefPubMed
24.
Dapri G, Cadiere G, Himpens J. Laparoscopic seromyotomy for long stenosis after sleeve gastrectomy with or without duodenal switch. Obes Surg. 2009;19:495–9.CrossRefPubMed
25.
26.
Greenstein AJ, Vine AJ, Jacob BP. When sleeve gastrectomy fails: adding a laparoscopic adjustable gastric band to increase restriction. Surg Endosc. 2009;23:884.CrossRefPubMed
27.
Miguel GP, Azevedo JL, Gicovate Neto C, et al. Glucose homeostasis and weight loss in morbidly obese patients undergoing banded sleeve gastrectomy: a prospective clinical study. Clinics (Sao Paulo). 2009;64:1093–8.
28.
le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243:108–14.CrossRefPubMed
29.
Schwartz MW, Woods SC, Porte D Jr, et al. Central nervous system control of food intake. Nature. 2000;404:661–71.PubMed
30.
Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992–5.CrossRefPubMed
31.
Nagaya N, Kojima M, Uematsu M, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1483–7.PubMed
32.
Horvath TL, Diano S, Sotonyi P, et al. Ghrelin and the regulation of energy balance: a hypothalamic perspective. Endocrinology. 2001;142:4163–9.CrossRefPubMed
33.
Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf). 2002;56:203–6.CrossRef
34.
Tolle V, Kadem M, Bluet-Pajot MT, et al. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab. 2003;88:109–16.CrossRefPubMed
35.
Shimizu Y, Nagaya N, Isobe T, et al. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res. 2003;9:774–8.PubMed
36.
Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology. 2002;123:1120–8.CrossRefPubMed
37.
Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194–8.CrossRefPubMed
38.
Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50:1714–9.CrossRefPubMed
39.
40.
Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetite stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 2001;120:337–45.CrossRefPubMed
41.
Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276:905–8.CrossRefPubMed
42.
Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and GH secretion. Endocrinology. 2000;141:4325–8.CrossRefPubMed
43.
Pardina E, Lopez-Tejero MD, Llamas R, et al. Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients. Obes Surg. 2009;19:1414–23.CrossRefPubMed
44.
Lin E, Gletsu N, Fugate K, et al. Ghrelin levels in the morbidly obese. Arch Surg. 2004;139:780–4.CrossRefPubMed
45.
Tschöp M, Viswanath D, Weyer C, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50:707–9.CrossRefPubMed
46.
Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2002;87:240–4.CrossRefPubMed
47.
van Dielen FM, van't Veer C, Buurman WA, et al. Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab. 2002;87:1708–16.CrossRefPubMed
48.
Ybarra J, Bobbioni-Harsch E, Chassot G, et al. Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss. Obes Surg. 2009;19:327–31.CrossRefPubMed
49.
Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 2001;86:4753–8.CrossRefPubMed
50.
Moller N, Nygren J, Hansen TK, et al. Splachnic release of ghrelin in humans. J Clin Endocrinol Metab. 2003;88:850–2.CrossRefPubMed
51.
Lee HM, Wang G, Englander EW, et al. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology. 2002;143:185–90.CrossRefPubMed
52.
Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–30.CrossRefPubMed
53.
Langer F, Reza Hoda M, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–9.CrossRefPubMed
54.
Wang Y, Liu J. Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy. Obes Surg. 2009;19:357–62.CrossRefPubMed
55.
Adami GF, Cordera R, Marinari G, et al. Plasma ghrelin concentration in the short-term following biliopancreatic diversion. Obes Surg. 2003;13:889–92.CrossRefPubMed
56.
Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247:401–7.CrossRefPubMed
57.
Hyland NP, Pittman QJ, Sharkey KA. Peptide YY containing enteroendocrine cells and peripheral tissue sensitivity to PYY and PYY(3-36) are maintained in diet-induced and diet-resistant rats. Peptides. 2007;28:1185–90.CrossRefPubMed
58.
Wapnir RA, Teichberg S. Regulation mechanisms of intestinal secretion: implications in nutrient absorption. J Nutr Biochem. 2002;13:190–9.CrossRefPubMed
59.
Koda S, Date Y, Murakami N, et al. The role of the vagal nerve in peripheral PYY 3-36-induced feeding reduction in rats. Endocrinology. 2005;146:2369–75.CrossRefPubMed
60.
Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY(3-36). N Engl J Med. 2003;349:941–8.CrossRefPubMed
61.
Spiller RC. Effects of serotonin on intestinal secretion and motility. Curr Opin Gastrenterol. 2001;17:99–103.CrossRef
62.
Boey D, Heilbronn L, Sainsbury A, et al. Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes. Neuropeptides. 2006;40:317–24.CrossRefPubMed
63.
Jackson PJ, Douglas NR, Chai B, et al. Structural and molecular evolutionary analysis of agouti and agouti-related proteins. Chem Biol. 2006;13:1297–305.CrossRefPubMed
64.
65.
Banks WA, Kastin AJ, Huang W, et al. Leptin enters the brain by a saturable system independent of insulin. Peptides. 1996;17:305–11.CrossRefPubMed
66.
Kotidis E, Koliakos G, Baltzopoulos V, et al. Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment—a prospective study. Obes Surg. 2006;16:1425–32.CrossRefPubMed
67.
Kohno D, Nakata M, Maekawa F, et al. Leptin suppresses ghrelin-induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase- and phosphodiesterase 3-mediated pathway. Endocrinology. 2007;148:2251–63.CrossRefPubMed
68.
Wickremesekera K, Miller G, Naotunne TD, et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg. 2005;15:474–81.CrossRefPubMed
69.
Ballantyne GH, Farkas D, Laker S, et al. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006;16:1189–97.CrossRefPubMed
70.
Adami GF, Cordera R, Camerini G, et al. Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion. J Surg Res. 2003;113:217–21.CrossRefPubMed
71.
Sarson DL, Scopinaro N, Bloom SR. Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes. 1981;5:471–80.PubMed
72.
Vidal J, Ibarzabal A, Romero F, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008;18:1077–82.CrossRefPubMed
73.
Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16:1138–44.CrossRefPubMed
74.
Rizzello M, Abbatini F, Casella G, et al. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg. 2010;20:50–5.CrossRefPubMed
75.
Yada T, Dezaki K, Sone H, et al. Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev. 2008;4:18–23.CrossRefPubMed
76.
Bergmann JF, Chassany O, Petit A, et al. Correlation between echographic gastric emptying and appetite: influence of psyllium. Gut. 1992;33:1042–3.CrossRefPubMed
77.
Verdich C, Madsen JL, Toubro S, et al. Effect of obesity and major weight reduction on gastric emptying. Int J Obes. 2000;24:899–905.CrossRef
78.
Mason EE. Gastric emptying controls type 2 diabetes mellitus. Obes Surg. 2006;17:853–5.CrossRef
79.
Naslund E, Backman L, Holst H, et al. Importance of small bowel peptides for improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg. 1998;8:253–60.CrossRefPubMed
80.
Flatt PR, Green BD. Nutrient regulation of pancreatic β-cell function in diabetes: problems and potentional solutions. Biochem Soc Trans. 2006;34:774–8.CrossRefPubMed
81.
Flint A, Raben A, Astrup A, et al. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998;101:515–20.CrossRefPubMed
82.
Pereferrer FS, Gonzàlez MH, Rovira AF, et al. Influence of sleeve gastrectomy on several experimental models of obesity: metabolic and hormonal implications. Obes Surg. 2008;18:97–108.CrossRefPubMed
83.
Melissas J, Koukouraki S, Askoxylakis J, et al. Sleeve gastrectomy: a restrictive procedure? Obes Surg. 2007;17:57–62.CrossRefPubMed
84.
Bernstine H, Tzioni-Yehoshua R, Groshar D, et al. Gastric emptying is not affected by sleeve gastrectomy—scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum. Obes Surg. 2009;19:293–8.CrossRefPubMed
Metadata
Title
Morbid Obesity and Sleeve Gastrectomy: How Does It Work?
Authors
Joanna Papailiou
Konstantinos Albanopoulos
Konstantinos G. Toutouzas
Christos Tsigris
Nikolaos Nikiteas
George Zografos
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 10/2010
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-010-0148-5

Other articles of this Issue 10/2010

Obesity Surgery 10/2010 Go to the issue

Clinical Research

Laparoscopic Versus Open Biliopancreatic Diversion: A Prospective Comparative Study

Clinical Research

Laparoscopic Sleeve Gastrectomy: An Indian Experience—Surgical Technique and Early Results

Clinical Research

Do Gastric Bypass Patient Characteristics, Behavior, and Health Differ Depending upon how Successful Weight Loss is Defined?

Clinical Report

Use of the PlasmaJet® System in Patients Undergoing Abdominal Lipectomy Following Massive Weight Loss: A Randomized Controlled Trial

Case Report

Thoracic Empyema After Laparoscopic Adjustable Gastric Banding. A Rare Complication

Allied Care

Effect of Different Bariatric Operations on Food Tolerance and Quality of Eating